Turn Therapeutics, Inc. (TTRX)
8.48
-0.16
(-1.85%)
USD |
NASDAQ |
Nov 20, 10:35
Turn Therapeutics Cash from Operations (Quarterly) : -1.549M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.549M |
| June 30, 2026 | -0.9234M |
| March 31, 2026 | -1.633M |
| December 31, 2025 | -1.176M |
| Date | Value |
|---|---|
| September 30, 2025 | -0.5886M |
| June 30, 2025 | -0.50M |
| March 31, 2025 | -0.2981M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Journey Medical Corp. | -3.437M |
| ANI Pharmaceuticals, Inc. | 83.79M |
| Corcept Therapeutics, Inc. | 142.89M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 7.72B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0161M |
| Cash from Financing (Quarterly) | 1.641M |
| Free Cash Flow | -5.347M |
| Free Cash Flow Per Share (Quarterly) | -0.0519 |
| Free Cash Flow to Equity (Quarterly) | -1.676M |
| Free Cash Flow to Firm (Quarterly) | -1.224M |
| Free Cash Flow Yield | -2.07% |